This seminar will provide practical advice on the borderline issues concerning these combination products and provide key guidance on the regulatory strategy to follow.
Drug/Device and Device/Drug Combinations in the EU and USA
Nov 8th, 2017Nov 9th, 2017
Latest in Home
Cardiac MRI-based ML model predicts MACE risk for STEMI patients
February 17, 2026
Low-value x-ray persists in patients with maxillofacial trauma
February 17, 2026
'Quadruple low' PCCT protocol improves lung cancer imaging
February 17, 2026
New benchmark helps monitor cumulative CT radiation dose
February 13, 2026














